Salience Labs Ltd
13034188
Healthy
No risk factors detected.
Details
Compliance
Last accounts
31/12/2024
small
Next accounts due
30/09/2026
Confirmation statement
Last: 19/11/2025
Due 03/12/2026
Industry
Officers
director · Since 20/11/2020
CHIEF EXECUTIVE OFFICER
SINGAPOREAN · UNITED KINGDOM · Age 32
Also on 1 other board
director · Since 13/02/2026
BRITISH · UNITED KINGDOM · Age 34
Also on 4 other boards
Former
director · Resigned 24/12/2021
director · Resigned 28/02/2024
director · Resigned 15/03/2024
director · Resigned 20/12/2024
director · Resigned 13/02/2026
Persons with Significant Control
Former PSCs
Vayshnavee Kewada
Ceased 31/03/2021
Mr Harish Bhaskaran
Ceased 31/03/2021
Mr Wolfram Hans Peter Pernice
Ceased 31/03/2021
Oxford Science Enterprises Plc
Ceased 30/06/2024
Oxford Science Enterprises Plc
Ceased 14/07/2025
Change History
Active
Private Limited Company
30 UPPER HIGH STREET
THAME
CompanyRankvs 1948+ SIC 72190 peers66
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/12/2025
Net Worth
£32
Balance sheet strength
Cash
£7.5M
Cash in the bank
Net Current Assets
£19.7M
Working capital
Current Assets
£20.7M
Current Liabilities
£1.0M
Fixed Assets
£1.6M
Debtors
£3.7M
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | 20.39 | — |
| 2024 | 27.25 | +£20.4M |
| 2023 | 21.32 | — |
Derived from filed accounts. Not audited figures.